A Paradigm Shift in the Management of Vascular Eye Disease

The management of vascular eye disease is undergoing a significant transformation with the introduction of innovative technologies like the OculoPULSE Choroidal Circulation Analyzer (CCA). By providing critical insights into ocular blood flow and circulation parameters, OculoPULSE aims to enhance our understanding of disease progression and treatment efficacy, ultimately improving patient outcomes.

Current Disease Cycle

Changing the Disease Cycle with OculoPULSE CCA

This paradigm shift in managing vascular-related eye diseases opens up numerous opportunities for improved clinical practices through the utilization of OculoPULSE.

Key Benefits of OculoPULSE in Eye Disease Management

The OculoPULSE CCA facilitates the measurement of essential eye circulation parameters, leading to the development of innovative biomarkers:
  • New Functional Biomarkers for Tracking Disease Progression
  • New Biomarkers for Developing Targeted Therapeutics
  • New Biomarkers for Assessing the Effectiveness of Treatments
Three blue-tinted lenses showcasing optical product design

OculoPULSE Choroidal Circulation Analyzer (CCA)

The OculoPULSE Choroidal Circulation Analyzer is a pneumotonometer that precisely measures critical eye circulation metrics.

OculoPULSE-CCA Key Parameters

  • Time-Resolved Recorded & Calculated Mean Intraocular Pressure
  • Intraocular Pressure Pulse Amplitude
  • Pulsatile Ocular Blood Volume
  • Pulsatile Ocular Blood Flow
  • Mean Ocular Perfusion Pressure
  • Autoregulation Index or Postural Response
By integrating these advanced measurements into clinical practice, healthcare providers can better manage vascular eye diseases and significantly enhance treatment strategies.
Learn More
Theresa Kramer, MD
Founder, President, CEO & CMOTel: (520) 904-7984Email
Address
12020 Deer Bit Lane, Suite AGlen Arm, MD 21057 Service Area: Nationwide with Future Global
Hours of Operation
Monday-Friday, 9 a.m.-5 p.m.
© 2026 OculoPULSE. All rights reserved